Genzyme Expects to resume shipments June 20 of Thyrogen® (thyrotropin alfa for injection)

By June 17, 2011 August 8th, 2017 2011 News Releases, News Releases, Thyroid Cancer

Genzyme’s current expectation is that it will be able to resume shipments of Thyrogen® in the United States during the week of June 20th. Genzyme notifed U.S. health care providers today of this anticipated timing so that individual patient treatments could be scheduled appropriately. Genzyme qualified the notice as a “best estimate of anticipated resumption of U.S. Thyrogen® supply” and stated that the inventory is extremely limited so that even minor changes to their current manufacturing plan can impact the timing of Thyrogen® availability.